In asthma, dysregulation of these pathways—through chronic IRP2 activation, excessive NCOA4-mediated ferritin degradation, or hepcidin-induced iron retention—fosters an iron-rich milieu in the airways that drives ferroptosis, amplifies epithelial injury, and exacerbates immune dysfunction. This evidence concerns the gene IREB2 and asthma.